Studies have shown that removing harmful bacteria using antibiotics and increasing the abundance of bacteria with bile saline-hydrolyzing activity in the gut can mitigate the development of NAFLD and alter the composition of the bile acid pool and the farnesoid X receptor signaling pathway [29,30]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.